NFKB1 and diabetic polyneuropathy: Upregulated NFκB activation caused by advanced glycation end products was observed in peripheral nerves that contribute to diabetic polyneuropathy [21], while the suppression of NFκB alleviates the related symptoms in patients with diabetes [28,29].